Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report

Abstract

UNLABELLED A female in the Netherlands with severe autoimmune hemolytic anemia (AIHA) was treated with conventional corticosteroid (2 mg/kg/d in divided doses) and blood transfusions for 18 months without improvement. The presented patient responded to megadose methylprednisolone (MDMP) 30 mg/kg/d for 3 d, followed by 20 mg/kg for 4 d, and subsequently 10, 5, 2, and 1 mg/kg/d each for 1 week. CONFLICT OF INTEREST None declared.

DOI: 10.4274/Tjh.2012.0070

Extracted Key Phrases

1 Figure or Table

Cite this paper

@inproceedings{zsoylu2013MegadoseM, title={Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report}, author={Şinasi {\"{O}zsoylu and Henriette W A Berenschot}, booktitle={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year={2013} }